Personalised Medicine Approach For Fluoropyrimidine-based Therapies - Guidance for DPD testing
Posted on
New guidance, prepared by Dr Paul Ross at GSTT, has been published by the UK Chemotherapy Board and endorsed by the ACP.
The Association of Cancer Physicians
The ACP is recognised by the Royal College of Physicians and the Department of Health as the specialty association for medical oncologists. The executive committee is made up of democratically elected clinicians representing the views and concerns of the membership. Membership of the ACP gives medical oncologists an independent voice in the affairs of the Royal College of Physicians, the Joint Collegiate Council for Oncology (JCCO) and the Specialty Advisory Committee (SAC), who supervise training and accreditation.
Through this, we:
- Promote the views and interests of medical oncologists to the DoH and RCP
- Influence policy on consultant expansion
- Develop training curricula and the upcoming specialty examination
- Participate in NICE appraisal and guideline development
- Encourage the development of best practice to benefit patients
- Nominate members for National Clinical Excellence Awards
If you are working as a medical oncologist, or a trainee, in the UK then we would urge you to join. Details here.
COVID-19 Resources
To assist clinicians facing the current and significant challenges providing systemic therapies to cancer patients, the ACP is collating links to key relevant documents for medical oncologists. New and updated documents will be added as they are released but you are advised to familiarise yourself with these resources.
Latest News
Read More...
National Regimen-Specific Consent Forms - Publication Updates
Posted on
SACT consent forms are reviewed on a rolling basis, however of particular note is the recent update (May 2020) of all the breast-specific forms, to which many changes have been made.
ACP Medical Oncology Training Survey Report 2019
Posted on
The results of a recent survey of trainees in medical oncology have now published. The survey was carried out during Oct/Nov 2019 and addressed some issues of particular importance which are not necessarily covered by the annual GMC survey. The overall response rate to the survey was 32% and it is planned to repeat it in late 2022, following the introduction of anticipated changes to the medical ...Read More...